Literature DB >> 9597594

Bone growth after lengthening of the lower limb in children.

E Viehweger1, J C Pouliquen, B Kassis, C Glorion, J Langlais.   

Abstract

Femoral and tibial growth was studied in 6 children undergoing a femoral lengthening and 28 children a tibial lengthening. Growth of both femurs and tibiae was evaluated for 3 years both before and after the procedure. No significant growth disturbance was noted in femoral lengthenings of 14%. However, growth variations were constant after tibial lengthening of 18% on the average and could be correlated to the amount of lengthening. The consequences of these changes are limited in terms of final limb length because overgrowth of the femur often compensates for growth retardation of the tibia when tibial lengthening is less than 18%. Experimental and clinical studies assert that lengthenings of more than 30% can result in significant and definite growth retardation of the lengthened bone.

Entities:  

Mesh:

Year:  1998        PMID: 9597594     DOI: 10.1097/01202412-199804000-00013

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  4 in total

1.  Lengthening With External Fixation Is Effective in Congenital Femoral Deficiency.

Authors:  Daniel E Prince; John E Herzenberg; Shawn C Standard; Dror Paley
Journal:  Clin Orthop Relat Res       Date:  2015-07-21       Impact factor: 4.176

2.  Epidemiology and treatment outcome of congenital pseudarthrosis of the tibia.

Authors:  Joachim Horn; Harald Steen; Terje Terjesen
Journal:  J Child Orthop       Date:  2013-01-18       Impact factor: 1.548

3.  Residual bone growth after lengthening procedures.

Authors:  Pierre Journeau; Pierre Lascombes; Dominique Barbier; Dmitry Popkov
Journal:  J Child Orthop       Date:  2016-11-23       Impact factor: 1.548

4.  Growth rate after limb deformity correction by the Ilizarov method with or without knee joint distraction: lengthening in 30 children followed for at least 2 years.

Authors:  Hubert J Oostenbroek; Ronald Brand; Peter M van Roermund
Journal:  Acta Orthop       Date:  2009-06       Impact factor: 3.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.